期刊文献+

Glutamate and GABAA receptor crosstalk mediates homeostatic regulation of neuronal excitation in the mammalian brain 被引量:2

原文传递
导出
摘要 Maintaining a proper balance between the glutamate receptor-mediated neuronal excitation and the A type of GABA receptor(GABAAR)mediated inhibition is essential for brain functioning;and its imbalance contributes to the pathogenesis of many brain disorders including neurodegenerative diseases and mental illnesses.Here we identify a novel glutamate-GABAAR interaction mediated by a direct glutamate binding of the GABAAR.In HEK293 cells overexpressing recombinant GABAARs,glutamate and its analog ligands,while producing no current on their own,potentiate GABA-evoked currents.This potentiation is mediated by a direct binding at a novel glutamate binding pocket located at theα+/β−subunit interface of the GABAAR.Moreover,the potentiation does not require the presence of aγsubunit,and in fact,the presence ofγsubunit significantly reduces the potency of the glutamate potentiation.In addition,the glutamate-mediated allosteric potentiation occurs on native GABAARs in rat neurons maintained in culture,as evidenced by the potentiation of GABAAR-mediated inhibitory postsynaptic currents and tonic currents.Most importantly,we found that genetic impairment of this glutamate potentiation in knock-in mice resulted in phenotypes of increased neuronal excitability,including decreased thresholds to noxious stimuli and increased seizure susceptibility.These results demonstrate a novel cross-talk between excitatory transmitter glutamate and inhibitory GABAAR.Such a rapid and short feedback loop between the two principal excitatory and inhibitory neurotransmission systems may play a critical homeostatic role in fine-tuning the excitation-inhibition balance(E/I balance),thereby maintaining neuronal excitability in the mammalian brain under both physiological and pathological conditions.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2022年第11期4156-4173,共18页 信号转导与靶向治疗(英文)
基金 Canadian Institutes of Health Research(CIHR),Taiwan National Science Council(NSC 102–2320-B-039–038-MY3) Ministry of Science and Technology(MOST 104-2320-B-039-045-MY3,MOST107-2320-B039-060-MY3,MOST 107-2320-B-039-061-MY3,MOST 110-2320-B-039-010-MY3,and MOST 111-2321-B-A49-005-),China Medical University(CMU-107-Z-01,CMU108-MF-14) National Natural Science Foundation of China(82071395,82001158,32170959) Natural Science Foundation of Chongqing(cstc2020jcyj-zdxmX0004 and cstc2021ycjh-bgzxm0186) Science and Technology Research Program of Chongqing Municipal Education Commission(KJZD-K201900403) Innovation Research Group at Institutions of Higher Education in Chongqing(CXQTP19034) CQMU Program for Youth Innovation in Future Medicine(No.W0044).
  • 相关文献

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部